IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2017 Holdings

Filed 2018-02-13 | 4 holdings | $285.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Voyager Therapeutics, Inc.(VYGR)COM92915B106$155.9K9,391,17654.6%
Myokardia, Inc.COM62857M105$63.0K1,496,59822.1%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$38.9K3,048,78013.6%
Editas Medicine, Inc(EDIT)COM28106W103$27.8K906,1769.7%